ArticleCurrent drug metabolism2026
The Metabolites of Secoiridoid Enantiomers and Diastereomers with 9-Carbon Skeleton in
Article in Current drug metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionThe secoiridoid metabolites with a 10-carbon skeleton, such as gentiopicroside, swertiamarin, and sweroside, were identified as the main components in Gentiana macrophylla. However, various unpredictable rearrangement metabolites might be generated due to the high reactivity of the hemiacetal in their structures. Thus, our ongoing research aimed to explore additional metabolites with new carbon skeleton features from G. macrophylla.
methodsMetabolites were separated and purified using multi-chromatographic techniques, such as silica gel, HP-20 resin gel, LH-20 dextran gel, C18 gel, and chiral CHIRALPAK AD-H column chromatography; and characterized by multi-spectroscopic methods, including NMR and X-ray spectroscopy, experimental CD measurement compared with ECD calculation, and carbon NMR calculation. Moreover, their biosynthetic pathways were deduced according to the KEGG pathway and their correlations with normal secoiridoid metabolites in G. macrophylla.
resultsA pair of norsecoiridoid diastereomers, (3R, 6R, 8S)-3-methoxy-6-hydroxy-swerimuslactone A (1) and (3S, 6R, 8R)-3-methoxy-6-hydroxy-swerimuslactone A (2), were isolated and identified from G. macrophylla, along with two pairs of racemates (3) and (4) with [α]²⁰_D = 0. These racemates were further separated by chiral column chromatography into two pairs of norsecoiridoid enantiomers: (-)-(5S, 8S)- gentimaclactone A (3a) and (+)-(5R, 8R)-gentimaclactone A (3b), and (+)-(3S, 8R)-swerimilegenin E (4a) and (-)-(3R, 8S)-swerimilegenin E (4b), respectively. DISCUSSION: All compounds were determined to have a 9-carbon skeleton, derived from the normal 10- carbon secoiridoids in G. macrophylla. Their biosynthetic pathways were deduced to occur via ring-opening of the hemiacetal at C-1, ring-closing with the hydroxyl group at C-8, followed by degradation of a CHO group.
conclusionFour norsecoiridoids with a 9-carbon skeleton, derived from the normal 10-carbon secoiridoids, were isolated from G. macrophylla. They were present as pairs of diastereomers or racemates, which were further separated into pairs of enantiomers. Among them, the diastereomer pair (3R, 6R, 8S)- 3-methoxy-6-hydroxy-swerimuslactone A (1) and (3S, 6R, 8R)-3-methoxy-6-hydroxy-swerimuslactone A (2), and the enantiomer pair (-)-(5S, 8S)-gentimaclactone A (3a) and (+)-(5R, 8R)-gentimaclactone A (3b) were identified as new compounds. Additionally, the plausible biosynthetic pathways of these compounds were proposed for future studies.
Indexed as
Identifiers
42836504What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.